Dr Reddys Laboratories (RDY) Gross Margin (2016 - 2025)
Historic Gross Margin for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to 53.63%.
- Dr Reddys Laboratories' Gross Margin fell 50500.0% to 53.63% in Q4 2025 from the same period last year, while for Dec 2025 it was 75.29%, marking a year-over-year decrease of 17700.0%. This contributed to the annual value of 58.51% for FY2025, which is 800.0% down from last year.
- Per Dr Reddys Laboratories' latest filing, its Gross Margin stood at 53.63% for Q4 2025, which was down 50500.0% from 55.56% recorded in Q1 2025.
- In the past 5 years, Dr Reddys Laboratories' Gross Margin ranged from a high of 59.59% in Q3 2024 and a low of 0.0% during Q3 2022
- Moreover, its 5-year median value for Gross Margin was 57.24% (2022), whereas its average is 52.9%.
- Its Gross Margin has fluctuated over the past 5 years, first crashed by -537800bps in 2022, then skyrocketed by 586700bps in 2023.
- Dr Reddys Laboratories' Gross Margin (Quarter) stood at 52.91% in 2021, then increased by 8bps to 57.24% in 2022, then grew by 2bps to 58.5% in 2023, then increased by 0bps to 58.68% in 2024, then dropped by -9bps to 53.63% in 2025.
- Its Gross Margin stands at 53.63% for Q4 2025, versus 55.56% for Q1 2025 and 58.68% for Q4 2024.